Florent Gros is the founder of Priothera. Priothera has raised $30M in total funding. Latest round: Series A. Based in Saint-Louis, France.
Florent Gros is the Co-founder and CEO of Priothera, a late-stage biopharmaceutical company focused on developing innovative oncology treatments. The company specializes in creating therapies for hematologic cancers, particularly acute myeloid leukemia (AML), using sphingosine-1-phosphate (S1P) receptor modulators. Priothera successfully closed a Series A financing round of €30 million in October 2020 and received a European Union grant of nearly €685,000 in July 2025 for its MOTRANS clinical trial.
Full founder directory · Investor directory · Company funding database · Fundraising library